Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nano-Polymer Stents May Reach U.S. Market By 2007 At Half The Cost Of DES

This article was originally published in The Gray Sheet

Executive Summary

Polyphosphaze non-carbon-based nano-polymers potentially will offer the same anti-restenosis benefits as drug-eluting stents, but cost only slightly more than bare-metal versions, according to Götz Richter, MD/PhD, University of Heidelberg, Germany

You may also be interested in...

Can Better Polymers Challenge DES? Cost Barriers Spur German Alternative

Coronary stents coated with non-carbon-based polymers may prevent restenosis without bearing drugs, Götz Richter, MD/PhD, University of Heidelberg, Germany, asserted Nov. 18

The Quality Lowdown: On Redeploying Inspectors, API Suppliers Thanks To Coronavirus

US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.

Mallinckrodt's Opioid Resolution Through Generic Unit Bankruptcy May Be 'Test Case'

Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts